Table 2 Baseline characteristics of the study subjects

Gender

 Male

3/4

1/5

0.2060

 Female

1/4

4/5

Age (years)

40.00 ± 12.36

30.60 ± 13.92

0.3264

Diagnosis

 LADA

2/4

2/5

1.0000

 T1D

2/4

3/5

Course (months)

28.50 ± 21.05

15.00 ± 5.57

0.2052

FBG (mmol/L)

6.29 ± 1.34

6.02 ± 1.98

0.8221

2 h-PBG (mmol/L)

19.93 ± 2.95

15.92 ± 3.61

0.1178

FCP (pmol/L)

136.70 ± 69.05

114.70 ± 59.12

0.6221

2 h-PCP (pmol/L)

440.20 ± 143.30

536.60 ± 296.80

0.5733

2 h-CP AUC (pmol/L)

567.60 ± 175.10

668.00 ± 380.80

0.6440

HbA1c (%)

7.58 ± 1.15

7.60 ± 1.73

0.9825

INS dose (IU/kg/d)

0.50 ± 0.41

0.41 ± 0.18

0.6801